These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

813 related items for PubMed ID: 23981521

  • 1. Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review.
    Melek J, Sakuraba A.
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):32-44.e5. PubMed ID: 23981521
    [Abstract] [Full Text] [Related]

  • 2. The efficacy and safety of bisphosphonates for osteoporosis or osteopenia in Crohn's disease: a meta-analysis.
    Guo Z, Wu R, Gong J, Zhu W, Li Y, Li N, Li J.
    Dig Dis Sci; 2013 Apr; 58(4):915-22. PubMed ID: 23179146
    [Abstract] [Full Text] [Related]

  • 3. Treatment for osteoporosis in people with ß-thalassaemia.
    Bhardwaj A, Swe KM, Sinha NK, Osunkwo I.
    Cochrane Database Syst Rev; 2016 Mar 10; 3():CD010429. PubMed ID: 26964506
    [Abstract] [Full Text] [Related]

  • 4. Bone Loss Prevention of Bisphosphonates in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Hu Y, Chen X, Chen X, Zhang S, Jiang T, Chang J, Gao Y.
    Can J Gastroenterol Hepatol; 2017 Mar 10; 2017():2736547. PubMed ID: 28913325
    [Abstract] [Full Text] [Related]

  • 5. Bisphosphonates for osteoporosis in people with cystic fibrosis.
    Conwell LS, Chang AB.
    Cochrane Database Syst Rev; 2012 Apr 18; (4):CD002010. PubMed ID: 22513903
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of bisphosphonates in management of low bone density in inflammatory bowel disease: A meta-analysis.
    Yao L, Wang H, Dong W, Liu Z, Mao H.
    Medicine (Baltimore); 2017 Jan 18; 96(3):e5861. PubMed ID: 28099343
    [Abstract] [Full Text] [Related]

  • 7. Intravenous pamidronate in combination with calcium and vitamin D: highly effective in the treatment of low bone mineral density in inflammatory bowel disease.
    Stokkers PC, Deley M, Van Der Spek M, Verberne HJ, Van Deventer SJ, Hommes DW.
    Scand J Gastroenterol; 2006 Feb 18; 41(2):200-4. PubMed ID: 16484125
    [Abstract] [Full Text] [Related]

  • 8. Bisphosphonate use in children with cerebral palsy.
    Hurley T, Zareen Z, Stewart P, McDonnell C, McDonald D, Molloy E.
    Cochrane Database Syst Rev; 2021 Jul 05; 7(7):CD012756. PubMed ID: 34224134
    [Abstract] [Full Text] [Related]

  • 9. Bisphosphonates for osteoporosis in people with cystic fibrosis.
    Conwell LS, Chang AB.
    Cochrane Database Syst Rev; 2014 Mar 14; 2014(3):CD002010. PubMed ID: 24627308
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials.
    Chen L, Wang G, Zheng F, Zhao H, Li H.
    Osteoporos Int; 2015 Sep 14; 26(9):2355-63. PubMed ID: 25944731
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bisphosphonates for osteoporosis in nonmetastatic prostate cancer patients receiving androgen-deprivation therapy: a systematic review and meta-analysis.
    Ding H, Yang L, Du W, Teng Y, Fu SJ, Tao Y, Lu JZ, Wang ZP.
    Asian Pac J Cancer Prev; 2013 Sep 14; 14(5):3337-43. PubMed ID: 23803126
    [Abstract] [Full Text] [Related]

  • 17. Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis.
    Szafors P, Che H, Barnetche T, Morel J, Gaujoux-Viala C, Combe B, Lukas C.
    Osteoporos Int; 2018 Nov 14; 29(11):2389-2397. PubMed ID: 29909470
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation: A Meta-Analysis.
    Kan SL, Ning GZ, Chen LX, Zhou Y, Sun JC, Feng SQ.
    Medicine (Baltimore); 2016 Feb 14; 95(5):e2679. PubMed ID: 26844505
    [Abstract] [Full Text] [Related]

  • 19. Cost effectiveness of ibandronate for the prevention of fractures in inflammatory bowel disease-related osteoporosis: cost-utility analysis using a Markov model.
    Kreck S, Klaus J, Leidl R, von Tirpitz C, Konnopka A, Matschinger H, König HH.
    Pharmacoeconomics; 2008 Feb 14; 26(4):311-28. PubMed ID: 18370566
    [Abstract] [Full Text] [Related]

  • 20. Bisphosphonates for osteoporosis in people with cystic fibrosis.
    Brenckmann C, Papaioannou A.
    Cochrane Database Syst Rev; 2001 Feb 14; (4):CD002010. PubMed ID: 11687132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.